AU2002237527A1 - Method of synthesizing camptothecin-relating compounds - Google Patents
Method of synthesizing camptothecin-relating compoundsInfo
- Publication number
- AU2002237527A1 AU2002237527A1 AU2002237527A AU2002237527A AU2002237527A1 AU 2002237527 A1 AU2002237527 A1 AU 2002237527A1 AU 2002237527 A AU2002237527 A AU 2002237527A AU 2002237527 A AU2002237527 A AU 2002237527A AU 2002237527 A1 AU2002237527 A1 AU 2002237527A1
- Authority
- AU
- Australia
- Prior art keywords
- synthesizing camptothecin
- relating compounds
- relating
- compounds
- camptothecin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002194 synthesizing Effects 0.000 title 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001-45430 | 2001-02-21 | ||
| JP2001045430 | 2001-02-21 | ||
| JP2001-309322 | 2001-10-05 | ||
| JP2001309322 | 2001-10-05 | ||
| PCT/JP2002/001538 WO2002066416A1 (en) | 2001-02-21 | 2002-02-21 | Method of synthesizing camptothecin-relating compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002237527A1 true AU2002237527A1 (en) | 2003-02-27 |
| AU2002237527B2 AU2002237527B2 (en) | 2007-01-04 |
Family
ID=26609837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002237527A Ceased AU2002237527B2 (en) | 2001-02-21 | 2002-02-21 | Method of synthesizing camptothecin-relating compounds |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7126000B2 (en) |
| EP (1) | EP1378505B1 (en) |
| JP (2) | JP4210119B2 (en) |
| KR (2) | KR100858972B1 (en) |
| CN (1) | CN100408550C (en) |
| AR (2) | AR035684A1 (en) |
| AU (1) | AU2002237527B2 (en) |
| BG (2) | BG108031A (en) |
| BR (1) | BR0207470A (en) |
| CA (2) | CA2437702C (en) |
| CZ (1) | CZ20032470A3 (en) |
| EE (1) | EE05361B1 (en) |
| HU (1) | HUP0302755A3 (en) |
| IL (2) | IL156949A0 (en) |
| MX (1) | MXPA03007528A (en) |
| NO (2) | NO328628B1 (en) |
| NZ (2) | NZ527615A (en) |
| PL (2) | PL217238B1 (en) |
| RO (2) | RO125158A2 (en) |
| RU (1) | RU2308447C2 (en) |
| SK (2) | SK288149B6 (en) |
| TW (1) | TWI245768B (en) |
| WO (1) | WO2002066416A1 (en) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ299329B6 (en) * | 2003-08-26 | 2008-06-18 | Pliva-Lachema A.S. | Process for preparing 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxy camptothecin |
| CZ299593B6 (en) * | 2003-12-16 | 2008-09-10 | Pliva-Lachema A. S. | Process for preparing 7-ethyl-10-hydroxycamptothecine |
| US20080182990A1 (en) * | 2004-08-09 | 2008-07-31 | Shilpa Medicare Limited | Process for the Preparation of Irinotecan Hydrochloride Trihydrate |
| US20070254905A1 (en) * | 2004-11-05 | 2007-11-01 | Samyang Corporation | Pharmaceutical Formulation for Increasing Solubility of 10-Hydroxycamptothecin Compounds in Non-Aqueous Polar Solvents |
| EP1846412B1 (en) * | 2005-02-07 | 2009-10-21 | Fermion Oy | Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin |
| PL1928883T3 (en) * | 2005-02-08 | 2014-03-31 | Fermion Oy | Process for the preparation of irinotecan hydrochloride |
| WO2006084940A1 (en) * | 2005-02-08 | 2006-08-17 | Fermion Oy | Process for producing [1,4'] bipiperidinyl-1'-carbonyl chloride or hydrochloride thereof |
| US8112154B2 (en) * | 2005-04-13 | 2012-02-07 | The Cleveland Clinic Foundation | Systems and methods for neuromodulation using pre-recorded waveforms |
| TWI375678B (en) | 2005-06-09 | 2012-11-01 | Yakult Honsha Kk | A method of preparation of a tricyclic ketone |
| WO2007015259A2 (en) * | 2005-08-03 | 2007-02-08 | Avra Laboratories Pvt. Ltd. | Method of synthesizing key intermediates for the production of camptothecin derivatives |
| EP1803725A1 (en) * | 2005-12-13 | 2007-07-04 | W.C. Heraeus GmbH | Methods for preparing irinotecan |
| US9220889B2 (en) | 2008-02-11 | 2015-12-29 | Intelect Medical, Inc. | Directional electrode devices with locating features |
| CN101824038B (en) * | 2009-03-06 | 2013-08-21 | 复旦大学 | Camptothecin and method for preparing analogues thereof |
| EP2470258B1 (en) | 2009-08-27 | 2017-03-15 | The Cleveland Clinic Foundation | System and method to estimate region of tissue activation |
| JP5599094B2 (en) * | 2010-05-20 | 2014-10-01 | 国立大学法人 千葉大学 | Method for producing nitrile compound |
| WO2011159688A2 (en) | 2010-06-14 | 2011-12-22 | Boston Scientific Neuromodulation Corporation | Programming interface for spinal cord neuromodulation |
| US9227074B2 (en) | 2012-08-28 | 2016-01-05 | Boston Scientific Neuromodulation Corporation | Parameter visualization, selection, and annotation interface |
| AU2012294364A1 (en) | 2011-08-09 | 2014-03-20 | Boston Scientific Neuromodulation Corporation | Remote control for blind clinical trials of electrical stimulation |
| US9792412B2 (en) | 2012-11-01 | 2017-10-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for VOA model generation and use |
| US8722886B1 (en) * | 2012-11-13 | 2014-05-13 | Bionumerik Pharmaceuticals, Inc. | Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethylsilyl)ethyl camptothecin |
| US9959388B2 (en) | 2014-07-24 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for providing electrical stimulation therapy feedback |
| US10272247B2 (en) | 2014-07-30 | 2019-04-30 | Boston Scientific Neuromodulation Corporation | Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming |
| US10265528B2 (en) | 2014-07-30 | 2019-04-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for electrical stimulation-related patient population volume analysis and use |
| US9974959B2 (en) | 2014-10-07 | 2018-05-22 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters |
| ES2754649T3 (en) | 2014-10-22 | 2020-04-20 | Vivacitas Oncology Inc | Methods and systems for the synthesis of the camptothecin analog |
| US10780283B2 (en) | 2015-05-26 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
| WO2016191436A1 (en) | 2015-05-26 | 2016-12-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
| US20160375248A1 (en) | 2015-06-29 | 2016-12-29 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects |
| WO2017003947A1 (en) | 2015-06-29 | 2017-01-05 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters by targeting and steering |
| EP3359252B1 (en) | 2015-10-09 | 2020-09-09 | Boston Scientific Neuromodulation Corporation | System and methods for clinical effects mapping for directional stimulations leads |
| US10716942B2 (en) | 2016-04-25 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | System and methods for directional steering of electrical stimulation |
| EP3458152B1 (en) | 2016-06-24 | 2021-04-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for visual analytics of clinical effects |
| WO2018044881A1 (en) | 2016-09-02 | 2018-03-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and directing stimulation of neural elements |
| US10780282B2 (en) | 2016-09-20 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters |
| AU2017341910B2 (en) | 2016-10-14 | 2020-05-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for closed-loop determination of stimulation parameter settings for an electrical simulation system |
| CN110167629B (en) | 2017-01-03 | 2023-07-18 | 波士顿科学神经调制公司 | System and method for selecting MRI compatible stimulation parameters |
| ES2821752T3 (en) | 2017-01-10 | 2021-04-27 | Boston Scient Neuromodulation Corp | Systems and procedures for creating stimulation programs based on user-defined areas or volumes |
| US10625082B2 (en) | 2017-03-15 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Visualization of deep brain stimulation efficacy |
| WO2018187090A1 (en) | 2017-04-03 | 2018-10-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
| CN110944710B (en) | 2017-07-14 | 2023-12-29 | 波士顿科学神经调制公司 | System and method for estimating clinical effects of electrical stimulation |
| US10960214B2 (en) | 2017-08-15 | 2021-03-30 | Boston Scientific Neuromodulation Corporation | Systems and methods for controlling electrical stimulation using multiple stimulation fields |
| US11285329B2 (en) | 2018-04-27 | 2022-03-29 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and programming electrical stimulation |
| WO2019210202A1 (en) | 2018-04-27 | 2019-10-31 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
| WO2020148641A1 (en) * | 2019-01-15 | 2020-07-23 | Laurus Labs Limited | Process for preparation of 2-amino-5-hydroxy propiophenone |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5391745A (en) | 1992-07-23 | 1995-02-21 | Sloan-Kettering Institute For Cancer Research | Methods of preparation of camptothecin analogs |
| JPH07101956A (en) * | 1993-10-05 | 1995-04-18 | Tanabe Seiyaku Co Ltd | Production of hydroxycamptothecin compound |
| KR960029336A (en) * | 1995-01-09 | 1996-08-17 | 김충환 | Camptothecin derivatives, preparation method thereof and anticancer agent containing same |
| JPH08225482A (en) * | 1995-02-22 | 1996-09-03 | Dai Ichi Seiyaku Co Ltd | Tetralone-related compound and its production |
| IL117684A (en) | 1995-04-07 | 2002-02-10 | Pharmacia & Upjohn Inc | Intermediates and process for the manufacture of camptothesin derivatives (cpt-11) and related compounds |
| ATE301659T1 (en) | 1995-11-02 | 2005-08-15 | Osi Pharm Inc | METHOD FOR PRODUCING CAMPOTHECINE DERIVATIVES |
| SG88737A1 (en) * | 1996-10-30 | 2002-05-21 | Tanabe Seiyaku Co | S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
-
2002
- 2002-02-20 TW TW091102967A patent/TWI245768B/en not_active IP Right Cessation
- 2002-02-20 AR ARP020100579A patent/AR035684A1/en active IP Right Grant
- 2002-02-21 KR KR1020037010841A patent/KR100858972B1/en active IP Right Grant
- 2002-02-21 IL IL15694902A patent/IL156949A0/en unknown
- 2002-02-21 CA CA2437702A patent/CA2437702C/en not_active Expired - Fee Related
- 2002-02-21 CZ CZ20032470A patent/CZ20032470A3/en unknown
- 2002-02-21 HU HU0302755A patent/HUP0302755A3/en unknown
- 2002-02-21 NZ NZ52761502A patent/NZ527615A/en not_active IP Right Cessation
- 2002-02-21 KR KR1020077030609A patent/KR100864692B1/en active IP Right Grant
- 2002-02-21 EE EEP200300373A patent/EE05361B1/en not_active IP Right Cessation
- 2002-02-21 US US10/467,987 patent/US7126000B2/en not_active Expired - Lifetime
- 2002-02-21 RU RU2003128530/04A patent/RU2308447C2/en not_active IP Right Cessation
- 2002-02-21 PL PL399009A patent/PL217238B1/en unknown
- 2002-02-21 MX MXPA03007528A patent/MXPA03007528A/en active IP Right Grant
- 2002-02-21 SK SK5001-2011A patent/SK288149B6/en not_active IP Right Cessation
- 2002-02-21 EP EP02703874.4A patent/EP1378505B1/en not_active Expired - Lifetime
- 2002-02-21 SK SK1147-2003A patent/SK288073B6/en not_active IP Right Cessation
- 2002-02-21 PL PL363440A patent/PL218065B1/en unknown
- 2002-02-21 RO ROA200900165A patent/RO125158A2/en unknown
- 2002-02-21 AU AU2002237527A patent/AU2002237527B2/en not_active Ceased
- 2002-02-21 JP JP2002565934A patent/JP4210119B2/en not_active Expired - Fee Related
- 2002-02-21 CN CNB028053230A patent/CN100408550C/en not_active Expired - Fee Related
- 2002-02-21 CA CA2683768A patent/CA2683768C/en not_active Expired - Fee Related
- 2002-02-21 WO PCT/JP2002/001538 patent/WO2002066416A1/en active IP Right Grant
- 2002-02-21 BR BRPI0207470-2A patent/BR0207470A/en not_active IP Right Cessation
- 2002-02-21 RO ROA200300695A patent/RO122639B9/en unknown
-
2003
- 2003-07-15 IL IL156949A patent/IL156949A/en not_active IP Right Cessation
- 2003-07-25 BG BG108031A patent/BG108031A/en active Pending
- 2003-08-13 NO NO20033579A patent/NO328628B1/en not_active IP Right Cessation
- 2003-08-14 NZ NZ534374A patent/NZ534374A/en not_active IP Right Cessation
-
2006
- 2006-09-08 US US11/517,621 patent/US7378555B2/en not_active Expired - Lifetime
-
2008
- 2008-03-28 JP JP2008085358A patent/JP4805967B2/en not_active Expired - Lifetime
-
2009
- 2009-11-24 NO NO20093402A patent/NO331656B1/en not_active IP Right Cessation
-
2011
- 2011-08-11 AR ARP110102927A patent/AR082663A2/en not_active Application Discontinuation
-
2013
- 2013-04-23 BG BG10111453A patent/BG111453A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002237527A1 (en) | Method of synthesizing camptothecin-relating compounds | |
| IL156949A0 (en) | Method of synthesizing camptothecin-relating compounds | |
| AU2001284697A1 (en) | Method of synthesizing diketopiperazines | |
| AU2002341629A1 (en) | Method of synthesizing molecular sieves | |
| AU2002360473A1 (en) | Method for preparation of three-demensional bodies | |
| AU2002302243A1 (en) | Method for determination of co-occurences of attributes | |
| AU2002361357A1 (en) | Method for monosulphonylation of an aminobenzofuran compound | |
| HUP0500644A3 (en) | Method of synthesizing phenol-containing compounds | |
| EP1243564A3 (en) | Process for preventing formation of scale | |
| AU2002329441A1 (en) | Process for the preparation of 3 - isochromanone | |
| AU2002358085A1 (en) | Process for the preparation of 4-methyl-7-aminoquinolones | |
| AU2003243432A1 (en) | Process of making phosphordiamidite compounds | |
| AU2003235231A1 (en) | Method of synthesizing cf3-chf-cf2-nr2 | |
| AU2002352909A1 (en) | Method of synthesizing a paclitaxel derivative | |
| AU2002324291A1 (en) | Process for the preparation of beta-ionylideneacetaldehyde | |
| AU2002355031A1 (en) | Method of synthesizing macrosphelides | |
| AU2002236882A1 (en) | Improved methods for synthesis of oligonucleotides | |
| AU2003235129A1 (en) | Process for preparation of 2-aminoketones | |
| AU2002344813A1 (en) | Methods for synthesizing substituted pyrimidines | |
| AU2002325110A1 (en) | Method for synthesizing oxazinones | |
| AU2002237529A1 (en) | Process for preparation of polyfluoroalkylsulfenyl compounds | |
| AUPR648501A0 (en) | Method of manufacture | |
| AU2002335518A1 (en) | Process for preparation of 5-halogenoindoles | |
| AU2002225009A1 (en) | Method of producing 1-alkyl-3-aryl-5-difluoromethoxy-1h-pyrazoles | |
| AU2002310979A1 (en) | Method of producing fluoroalkylphosphates |